Guideline | Management of pheochromocytoma and paraganglioma in patients harboring germline SDHD pathogenic variants
24 Apr, 2023 | 13:32h | UTCClinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants – The Lancet Diabetes & Endocrinology (free registration required)
Commentary on Twitter
https://twitter.com/TheLancetEndo/status/1647547884361981953